There is a growing clinical concern in India regarding the abuse potential of Tapentadol, as it is sometimes used as a substitute for other illicit or restricted opioids. Medical professionals emphasize that it should only be used for the and under strict supervision to avoid withdrawal symptoms or addiction.
Tapentadol is marketed under several trade names by major Indian pharmaceutical companies. Some of the most common brands include: (Glenmark Pharmaceuticals) Tydol (Ranbaxy Laboratories Ltd.) Tapal (MSN Laboratories) Tapenta (Zuventus Healthcare Ltd)
Do you need help finding or more details on specific brand pricing ?
: Available in immediate-release (IR) and extended-release (ER) forms ranging from 50 mg to 200 mg.